Literature DB >> 23821289

[Possible applications of new stem cell sources in neurology].

A Hermann1, A Storch, S Liebau.   

Abstract

Stem cells provide broad possibilities in modern science and medicine. This counts not only for investigations of developmental aspects but also for cell-based therapies, pharmacotoxicological testing and improvements in personalized medicine. The recent described techniques of induced pluripotent stem cells, directly induced neural stem cells and directly induced neurons are a major step forward by providing new possibilities for research on neurological diseases. Nevertheless, a variety of questions remain open regarding stem cell-based therapeutic strategies including tumorigenicity and phenotypical stability in the receptor brain. The major hope is that the new stem cell-based neural cell systems will help to understand the pathophysiology of neurodegenerative diseases. The future will show whether and how stem cells will lead to successful restorative therapies and/or to suitable cell models for neurological diseases.

Entities:  

Mesh:

Year:  2013        PMID: 23821289     DOI: 10.1007/s00115-013-3753-4

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  34 in total

1.  Genome-wide expression profiling and functional network analysis upon neuroectodermal conversion of human mesenchymal stem cells suggest HIF-1 and miR-124a as important regulators.

Authors:  Martina Maisel; Hans-Jörg Habisch; Loïc Royer; Alexander Herr; Javorina Milosevic; Andreas Hermann; Stefan Liebau; Rolf Brenner; Johannes Schwarz; Michael Schroeder; Alexander Storch
Journal:  Exp Cell Res       Date:  2010-06-23       Impact factor: 3.905

Review 2.  Induced neural stem cells (iNSCs) in neurodegenerative diseases.

Authors:  Andreas Hermann; Alexander Storch
Journal:  J Neural Transm (Vienna)       Date:  2013-05-30       Impact factor: 3.575

3.  Direct reprogramming of fibroblasts into neural stem cells by defined factors.

Authors:  Dong Wook Han; Natalia Tapia; Andreas Hermann; Kathrin Hemmer; Susanne Höing; Marcos J Araúzo-Bravo; Holm Zaehres; Guangming Wu; Stefan Frank; Sören Moritz; Boris Greber; Ji Hun Yang; Hoon Taek Lee; Jens C Schwamborn; Alexander Storch; Hans R Schöler
Journal:  Cell Stem Cell       Date:  2012-03-22       Impact factor: 24.633

Review 4.  Reprogramming of somatic cells.

Authors:  Johnson Rajasingh
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

Review 5.  Epigenetic conversion of human adult bone mesodermal stromal cells into neuroectodermal cell types for replacement therapy of neurodegenerative disorders.

Authors:  Andreas Hermann; Martina Maisel; Alexander Storch
Journal:  Expert Opin Biol Ther       Date:  2006-07       Impact factor: 4.388

6.  Intrastriatal transplantation of microcarrier-bound human retinal pigment epithelial cells versus sham surgery in patients with advanced Parkinson's disease: a double-blind, randomised, controlled trial.

Authors:  Robert E Gross; Raymond L Watts; Robert A Hauser; Roy Ae Bakay; Heinz Reichmann; Rüdiger von Kummer; William G Ondo; Elke Reissig; Wilhelm Eisner; Heike Steiner-Schulze; Harald Siedentop; Klaus Fichte; Walter Hong; Michael Cornfeldt; Katherine Beebe; Rupert Sandbrink
Journal:  Lancet Neurol       Date:  2011-05-10       Impact factor: 44.182

7.  Long-term safety and efficacy of human-induced pluripotent stem cell (iPS) grafts in a preclinical model of retinitis pigmentosa.

Authors:  Yao Li; Yi-Ting Tsai; Chun-Wei Hsu; Deniz Erol; Jin Yang; Wen-Hsuan Wu; Richard J Davis; Dieter Egli; Stephen H Tsang
Journal:  Mol Med       Date:  2012-12-06       Impact factor: 6.354

8.  Variation in the safety of induced pluripotent stem cell lines.

Authors:  Kyoko Miura; Yohei Okada; Takashi Aoi; Aki Okada; Kazutoshi Takahashi; Keisuke Okita; Masato Nakagawa; Michiyo Koyanagi; Koji Tanabe; Mari Ohnuki; Daisuke Ogawa; Eiji Ikeda; Hideyuki Okano; Shinya Yamanaka
Journal:  Nat Biotechnol       Date:  2009-07-09       Impact factor: 54.908

9.  Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression.

Authors:  Peter Reinhardt; Benjamin Schmid; Lena F Burbulla; David C Schöndorf; Lydia Wagner; Michael Glatza; Susanne Höing; Gunnar Hargus; Susanna A Heck; Ashutosh Dhingra; Guangming Wu; Stephan Müller; Kathrin Brockmann; Torsten Kluba; Martina Maisel; Rejko Krüger; Daniela Berg; Yaroslav Tsytsyura; Cora S Thiel; Olympia-Ekaterini Psathaki; Jürgen Klingauf; Tanja Kuhlmann; Marlene Klewin; Heiko Müller; Thomas Gasser; Hans R Schöler; Jared Sterneckert
Journal:  Cell Stem Cell       Date:  2013-03-07       Impact factor: 24.633

Review 10.  Neural stem cells and neurodegeneration.

Authors:  Alexander Storch; Johannes Schwarz
Journal:  Curr Opin Investig Drugs       Date:  2002-05
View more
  2 in total

Review 1.  [Cellular replacement strategies and adult neurogenesis in idiopathic Parkinson's disease].

Authors:  F Marxreiter; A Storch; J Winkler
Journal:  Nervenarzt       Date:  2016-08       Impact factor: 1.214

2.  Enzymatically Forming Intranuclear Peptide Assemblies for Selectively Killing Human Induced Pluripotent Stem Cells.

Authors:  Shuang Liu; Qiuxin Zhang; Adrianna N Shy; Meihui Yi; Hongjian He; Shijiang Lu; Bing Xu
Journal:  J Am Chem Soc       Date:  2021-09-16       Impact factor: 16.383

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.